← Eichor
Condition: Plasmablastic Lymphoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Plasmablastic Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
Phase 2 · 18 location(s) · Fondazione Italiana Linfomi - ETS · NCT04915248Study on Plasmablastic Lymphoma Patients
Phase N/A · 23 location(s) · Fondazione Italiana Linfomi - ETS · NCT06781359Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT053894233'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT07332507Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Diseas
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05907759A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
EARLY_Phase 1 · 8 location(s) · AIDS Malignancy Consortium · NCT04139304Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · 36 location(s) · Schrödinger, Inc. · NCT05544019
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.